FDA warns against using certain syringes and needles; seeks input on labeling medical device materials

May 20, 2021 - 02:57 PM
FDA

Health care providers should stop using certain syringes and needles with needle safety devices made by Guangdong Haiou Medical Apparatus Co. until further notice due to quality issues, including certain needles detaching from the syringe after injection and other needle safety device failures, the Food and Drug Administration said today in a letter to health care providers. The letter includes details on the syringe and needle configurations; recommendations for health care facility risk managers; and instructions for reporting problems with the devices. 
 
In other news, the FDA today released a discussion paper seeking input from stakeholders through July 19 on how to include specific materials information in medical device labeling to help patients and health care providers make informed decisions regarding medical device use. 
 

Related News Articles

Headline
AHA provides recommendations to Consumer Product Safety Commission on modernized product injury surveillance system
The AHA Aug. 12 provided comments to the Consumer Product Safety Commission on its agenda and priorities for fiscal years 2027 and 2028, specifically…
Headline
Highest FDA recall issued for certain convenience kits
The Food and Drug Administration Aug. 3 identified Class I recalls of two convenience kit products. Certain kits by Medline…
Headline
FDA identifies, issues Class 1 recalls
The Food and Drug Administration has identified a recall by Cook Medical of Zenith Alpha 2 Thoracic Endovascular Graft proximal components after Cook Medical…
Headline
FDA issues early alerts for certain Baxter, Abiomed products
The Food and Drug Administration has issued early alerts for certain Spectrum infusion pumps from Baxter and Abiomed Automated Impella Controllers. The agency…
Headline
FDA approves first semiannual HIV prevention drug
The Food and Drug Administration has approved a new, first-of-its-kind semiannual HIV prevention medication, Gilead Sciences announced June 18. The company…
Headline
White House announces tariffs on goods imported from Canada, Mexico, China
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China. The tariffs for Mexico and Canada have since been delayed…